Detalhe da pesquisa
1.
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy.
Cancer Immunol Immunother
; 70(7): 2073-2086, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439292
2.
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.
Proc Natl Acad Sci U S A
; 113(7): E874-83, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26831100
3.
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
Proc Natl Acad Sci U S A
; 110(20): E1857-66, 2013 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23630282
4.
IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation.
J Immunol
; 191(8): 4348-57, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24026079
5.
Endogenous CD28 drives CAR T cell responses in multiple myeloma.
bioRxiv
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562904
6.
Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression.
iScience
; 27(3): 109187, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38420590
7.
ß-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism.
JCI Insight
; 8(8)2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092550
8.
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
Front Oncol
; 13: 1120329, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816919
9.
Photodynamic therapy enhancement of anti-tumor immunity.
Photochem Photobiol Sci
; 10(5): 649-52, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21253659
10.
IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Lasers Surg Med
; 43(7): 676-85, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22057495
11.
Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9.
Cell Death Discov
; 7(1): 266, 2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584068
12.
Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53.
Cell Death Dis
; 12(6): 545, 2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039962
13.
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.
Commun Biol
; 4(1): 466, 2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846531
14.
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects.
PLoS One
; 15(2): e0227940, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027657
15.
The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.
Oncotarget
; 7(3): 2936-50, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26655090
16.
Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice.
Oncotarget
; 5(3): 802-14, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24583651
17.
Enhancement of anti-tumor immunity by photodynamic therapy.
Immunol Res
; 46(1-3): 216-26, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763892